Intuits Latest Earnings May Challenge Morgan Stanleys Stock Forecast Latin American Leaders at WUF13 Push for Housing Finance Reform and Climate Resilience Fatal Train Attack in Pakistan Could Heighten Security Risks for Regional Markets Tony Blairs Economic Blueprint Diagnosis on Point Prescription Under Fire Metas Two Developments Could Signal Stock Stabilization MedX Holdings Announces Q1 2026 Progress MultiCity Expansion and Rebranding to Dazed Inc DAZE IPHA Q1 2026 Earnings WiderthanExpected Loss Amid Pipeline Progress PLPC Q1 2026 Earnings EPS Surges 15 Above Estimates Amid Resilient Operations Marine Products Corporation MPX Q1 2026 Earnings Weak Profitability and Stock Decline Highlight Ongoing Challenges ADM Q1 2026 Earnings EPS Beat by 659 on Strong Operational Execution PTC Q1 2026 Earnings Strong EPS Surprise Drives Positive Market Response LMFA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Company Posts Zero Revenue Otis Worldwide OTIS Holds Steady Near Support as Consolidation Continues Everspin Technologies MRAM Rallies 379 Key Levels in Focus Krystal Biotech KRYS Edges Higher Key Support and Resistance Levels in Focus Tripcom TCOM Slides 3 as Market Sentiment Sours on Travel Demand Concerns Idea Acquisition Corp Units IACOU Holds Steady at 1000 Consolidation Phase Ahead Rain Enhancement Technologies RAIN Climbs 649 on Renewed Trading Interest Novo Nordisk NVO Climbs 215 as Shares Approach Key Resistance Near 48 Vuzix Corporation VUZI Surges 9 as Stock Tests Key Resistance at 540 Oak Woods Acquisition Corporation Warrant OAKUW Holds Near Penny Levels After Modest Gain Stardust Power Inc SDST Plunges 185 as Selling Pressure Intensifies Safehold Inc SAFE Holds Steady Near Support as Volume Normalizes Burberry Shares Surge on Speculation of Moncler Takeover Bid Lakeland Industries LAKE Q1 2026 Earnings Deep EPS Miss Masks Potential Recovery as Stock Rallies Capital One Financial COF Holds Steady Near Resistance as Volume Signals Caution WAFDP Q1 2026 Earnings Earnings Beat Estimates Amid Steady Performance SGMO Q1 2026 Earnings Gene Therapy Focus Drives Stock Higher Despite Deep EPS Miss BOH Q1 2026 Earnings EPS Misses Estimates as Stock Slips PRHIZ Q1 2024 Earnings Significant EPS Beat Surprises Markets Ernexa Therapeutics Inc ERNA Q3 2023 Earnings Narrowing Losses Amidst Pipeline Progress XPEV Q4 2025 Earnings A Stunning Profit Beat Drives Shares Higher HLMN Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment